News

Amsterdam Molecular Therapeutics BV (AMT) Acquires License to AAV Patents from Targeted Genetics Corporation

December 12, 2006

Human Health

Company

Back

Download

PDF

Not for distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan or SouthAfrica or to US persons. This announcement is not a prospectus and does not contain or constitute anoffer for sale or the solicitation of an offer to purchase securities in the United States, Canada, SouthAfrica, Australia, Japan or any other jurisdiction.